When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LLY - AbCellera Biologics: Potentially Worth Over $41 Currently Without COVID Revenues
Eli Lilly and Company
AbCellera has been pummeled in the market this year, dropping like a stone to the current price of just over $14 a share. I believe this is a huge mistake.
AbCellera currently has 131 programs with royalty agreements under contract and that number continues to grow fast.
Using a 10% discount rate, I estimate the current value of only the current programs at over $41. This estimate does not include any COVID revenues going forward.